Rizwan Romee, M.D.

Dana-Farber Cancer Institute

Disclosure(s): Crispr Therapeutics: Grant/Research Support; Glycostem Therapeutics: Advisor/Consultant; NK Therapeutics: Advisor/Consultant; Skyline Therapeutics: Grant/Research Support

Poster(s):

• 2098 - Cytomegalovirus (CMV) Infection Following Hematopoietic Cell Transplantation (HCT) with Post-transplant Cyclophosphamide (PTCy): Outcomes in Haploidentical versus Matched or Mismatched Unrelated Donor (MUD/MMURD) Allografts
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET